| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.0B | $3.8B | $3.6B | $2.6B | $1.5B | $1.2B | $0.2B | $0.2B |
| Cost of Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | $0.3B | $0.2B | $0.2B |
| Net Income | $2.8B | $2.7B | $2.5B | $1.1B | $1.0B | $0.9B | $0.1B | $0.1B |
| EPS (Basic) | $2.61 | $2.56 | $2.48 | $1.27 | $1.80 | $1.76 | $1.25 | $1.43 |
| EPS (Diluted) | $2.61 | $2.56 | $2.47 | $1.27 | $1.76 | $1.75 | $1.24 | $1.43 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $46.7B | $45.4B | $44.1B | $37.6B | $17.6B | $17.1B | $13.3B | $11.3B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.6B | $0.5B | $0.5B | $0.2B | $0.7B | $0.3B | $1.1B | $0.6B |
| Total Liabilities | $18.5B | $18.4B | $18.4B | $15.3B | $5.4B | $7.6B | $5.2B | $4.4B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $27.8B | $26.5B | $25.3B | $21.9B | $12.1B | $9.4B | $8.0B | $6.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.5B | $2.4B | $2.2B | $1.9B | $0.9B | $0.9B | $0.7B | $0.5B |
| Investing Cash Flow | $-0.9B | $-0.9B | $-2.9B | $-9.3B | $0.0B | $-4.5B | $-1.4B | $-1.1B |
| Capital Expenditures | — | — | — | — | — | — | $0.0B | $0.0B |
| Financing Cash Flow | $-1.6B | $-1.5B | $1.0B | $6.8B | $-0.5B | $2.9B | $1.2B | $1.0B |